German Pharmaceuticals & Biotech Big Green Snowflakes

Cantourage Group

Market Cap: €70.8m

Operates as a medical cannabis company in Europe and internationally.

Dermapharm Holding

Market Cap: €2.1b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

2invest

Market Cap: €62.9m

An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, IT sectors, and natural resources sectors in Germany and internationally.

Novogenia

Market Cap: €80.4m

Manufactures and sells personalized health products in global markets.

Merck KGaA

Market Cap: €63.1b

Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.

SCHOTT Pharma KGaA

Market Cap: €3.3b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

2invest

Market Cap: €43.8m

An investment company specializing in investments in capital and partnerships in the biotechnology, life science, IT sectors, and natural resources sectors in Germany and internationally.

MPH Health Care

Market Cap: €101.0m

An investment company, engages in the healthcare business in Germany.

Formycon

Market Cap: €334.7m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

Evotec

Market Cap: €616.8m

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Bayer

Market Cap: €46.8b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

Respiratorius

Market Cap: €17.5m

A research company, develops pharmaceuticals for the treatment of cancer.

PExA

Market Cap: €62.1m

Develops and commercializes diagnostic products for various respiratory diseases.

Genetic Analysis

Market Cap: €45.6m

A science-based diagnostic company, engages in the research, development, manufacturing, and sale of diagnostic test solutions for human microbiome in the United States, Europe, and internationally.

Biofrontera

Market Cap: €15.5m

A biopharmaceutical company, engages in the research, development, and distribution of dermatological products and medical products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.

TFF Pharmaceuticals

Market Cap: €9.7m

A clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia.

Gerresheimer

Market Cap: €973.3m

Provides drug containment solutions in Germany and internationally.

bioXXmed

Market Cap: €329.8k

An investment company, invests in biotechnology or medical technology companies with equity or debt capital.

Biomark Diagnostics

Market Cap: €33.9m

Develops early-stage cancer diagnostic technology platform to detect and treat cancer.

Heidelberg Pharma

Market Cap: €121.2m

A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, Europe, China, the United States, and internationally.

Dextech Medical

Market Cap: €192.3m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer in Sweden.

bioXXmed

Market Cap: €225.6k

A holding company, investing in biotechnology and medical technology companies.

PEPTONIC medical

Market Cap: €1.2b

A medical technology company, develops and sells intimate self-care products for women.

Hamlet BioPharma

Market Cap: €1.4b

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

SynBiotic

Market Cap: €7.4m

Engages in the pharmaceutical business in Germany and Europe.

Liminal BioSciences

Market Cap: €11.8m

Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom.

Epigenomics

Market Cap: €833.1k

Does not have significant operations.

Vitruvia Medical

Market Cap: €7.2m

A technology company, operates in the healthcare sector.

Vidac Pharma Holding

Market Cap: €23.9m

An investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases.

Paion

Market Cap: €392.4k

A specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide.

Cannovum Cannabis

Market Cap: €1.2m

Engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin.

co.don

Market Cap: €427.6k

Does not have significant operations.